SCHEMBL5576948

SCHEMBL5576948

CCOC1OC(CCO)C(CCO)O1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5576929 0.81 GAA (0.36)
SCHEMBL5576969 0.81 GAA (0.36)
SCHEMBL5576562 0.81 GAA (0.36)
SCHEMBL14422023 0.81 GAA (0.33)
SCHEMBL193551 0.75
SCHEMBL6434008 0.71
SCHEMBL5569891 0.70
SCHEMBL1449438 0.70
SCHEMBL5569893 0.70
SCHEMBL27936631 0.70

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7271274-B2 Phenolic antioxidants for the treatment of disorders including arthritis, asthma and coronary artery disease AHTEROGENICS, INC. (US) 2007-09-18 US disclosed
US-20060020038-A1 Phenolic antioxidants for the treatment of disorders including arthritis, asthma and coronary artery disease CRABTREE ACQUISITION CO, LLC 2006-01-26 US disclosed
WO-2005112914-A2 PHENOLIC ANTIOXIDANTS FOR THE TREATMENT OF DISORDERS INCLUDING ARTHRITIS, ASTHMA AND CORONARY ARTERY DISEASE ATHEROGENICS, INC. (US) 2005-12-01 WO disclosed